Historique de carrière de Robert F. McCullough
Anciens postes connus de Robert F. McCullough
Sociétés | Poste | Début | Fin |
---|---|---|---|
Summitcrest Capital, Inc.
Summitcrest Capital, Inc. Investment ManagersFinance Summitcrest Capital, Inc. provides investment advisory services. | President | 01/10/2003 | - |
Presidio Management | Corporate Officer/Principal | 01/04/1999 | 01/07/2003 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Directeur Général | 01/09/2005 | 03/04/2014 |
Président | 07/01/2010 | - | |
Directeur Financier/CFO | 01/09/2005 | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Chief Executive Officer | 1 |
Chairman | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Presidio Management | |
Summitcrest Capital, Inc.
Summitcrest Capital, Inc. Investment ManagersFinance Summitcrest Capital, Inc. provides investment advisory services. | Finance |
- Bourse
- Insiders
- Robert F. McCullough
- Expérience